Brook.ai just pulled a move that’ll make even the most jaded health exec sit up straighter. $28M in fresh Series B funding, co-led by UMass Memorial Health and Morningside, just landed in their pocket to supercharge how America handles chronic care. That’s not hype; that’s horsepower.
Oren Nissim, CEO & co-founder, didn’t come out of nowhere. The guy built Telmap, sold it to Intel, then flipped his focus from navigation for cars to navigation for bodies. Partnered with Kit Macgillivray, CPO & co-founder, who designs digital experiences like a chess player reading ten moves ahead, they turned Brook.ai into a living, breathing ecosystem for remote care. It’s healthcare without the waiting room, 24/7, continuous, human+AI support that actually delivers.
The results? Not vanity metrics, hard numbers. 204% patient growth this year, 82% retention, NPS of 66. Congestive heart failure readmissions cut by 90%. Hypertension control up 80% in 6 weeks. Erie County Medical Center saw blood pressure control jump from 37.4% to 67.7% in 12 weeks. That’s not a pilot program, that’s a system rewrite.
And they’re doing it with speed. Health systems go live in 30 days with zero capital expense. Plug in, integrate with your EMR, and the AI does the heavy lifting, trained on 5M+ patient messages across 6 years. It’s HIPAA-secure, SOC2 Type II tight, and governed to NIST & ISO standards. Brook’s even running daily LLM safety checks through its CI/CD pipelines, because in healthcare, “good enough” doesn’t cut it.
This round isn’t just more capital, it’s a signal. When a $3B health system like UMass Memorial Health invests in you and scales your product across its network, that’s validation money can’t buy. And Morningside doesn’t throw checks for headlines, they bet on long-term category dominance.
Oren Nissim and Kit Macgillivray have built a company that proves you can merge compassion and computation, care and code. Dr. Mike Merrill, CMO, and Alex Foley, CNO, bring the clinical backbone. CRO John Stamatopoulos, VP of Eng Tal Amitay, and the leadership crew, Kelsey Salle, Gregg Santabarbara, Luke O’Brien, Andrew Rosenthal, Tricia Sheehan, are setting the tempo.
With $32.25M raised to date, Brook.ai is scaling faster than the market it’s reshaping. The $20.8B chronic disease management market and $110.7B remote monitoring space aren’t waiting for slow movers. This is healthcare’s streaming moment, and Brook.ai just hit play.
